Landmarkbio
About Landmarkbio
Landmarkbio is a Healthcare company, and was acquired by Artis BioSolutions in April 2025. Cell and gene therapy development and manufacturing services are provided. Its focus areas include Medical Research Labs. Its legal entity is Landmark Bio® LLC.
Company details
Services in cell and gene therapy manufacturing are offered by Landmarkbio, a biotechnology firm focused on process and analytical development, formulation, fill and finish operations, quality control testing, and CMC regulatory consulting. Additional support includes IND-enabling activities and technology advancements for modalities such as viral vectors, nucleic acids, extracellular vesicles, and nanoparticles. Flexible partnerships are available for academic, hospital, and industry collaborators across various project stages.
- Stage Acquired
- SectorsHealthcare
- Website landmarkbio.com
- Social LinkedIn
- Acquired by Artis BioSolutions (Apr 2025)
- Legal Name Landmark Bio® Llc
- Investors
- Acquired byArtis BioSolutions
(Apr 2025)
Investors in Landmarkbio
Landmarkbio has secured backing from 1 investor. Prominent investors backing the company include Artis BioSolutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| artisbiosolutions.com |
Investor details for Landmarkbio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Landmarkbio
40 people are tracked at Landmarkbio (21 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
Shanti Chari | VP - Digital Technolgies & Innovation | Leadership |
Aileen Baquiran | VP, Business Operations | Leadership |
Ran Zheng | Chief Executive Officer | Leadership |
Eric Batchelder | Director, Facilities Operations | Leadership |
Eli Kraus | Associate Vice President For Analytical and Process Development | Leadership |
Gregg Nyberg | Chief Technology Officer | Leadership |
Michael Covington | Chief Quality and Regulatory Officer | Leadership |
Olga Mollin | VP, Watertown Site Head Technical Operations | Leadership |
Raj Sonarikar | Director SAP Center Of Excellence | Leadership |
Zack Denoncour | Director Of Engineering And Technology | Leadership |
Robert Delong | Senior Scientific Director | Leadership |
Kris Ward | Vice President Corporate Development & Licensing | Leadership |
Alma Ines O. | Director Of Business Development | Leadership |
Radouane zouaoui | Scientific Director | Leadership |
Jamie McGrath, SHRM-SCP | Senior Director Of People Operations (head Of People Team) | Leadership |
David Calligaris | Associate Director, Program Management | Leadership |
Mike Sousa | Vice President, Quality Site Head | Leadership |
Kevin Lind | Associate Director - Digital Platforms | Leadership |
Mandy McNiel | Senior Director Supply Chain | Leadership |
Gary Woo | Sr Director Digital Platforms | Leadership |
20 more people are available in the full profile.
Complete people profiles for Landmarkbio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Landmarkbio
The website of Landmarkbio (landmarkbio.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 45.1% vs previous month
Websites whose visitors overlap most with Landmarkbio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fluentbio.com | 100% | 4.7K | #3,913,179 | View details | |
| cuebiopharma.com | 99% | 4.9K | #7,063,180 | View details | |
| werewolftx.com | 97% | 4.5K | #3,895,284 | View details | |
| arkudatx.com | 95% | View details | |||
| avencell.com | 95% | 1.9K | #9,657,603 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Landmarkbio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Landmarkbio
Services in cell and gene therapy manufacturing are offered by Landmarkbio, a biotechnology firm focused on process and analytical development, formulation, fill and finish operations, quality control testing, and CMC regulatory consulting. Additional support includes IND-enabling activities and technology advancements for modalities such as viral vectors, nucleic acids, extracellular vesicles, and nanoparticles. Flexible partnerships are available for academic, hospital, and industry collaborators across various project stages.
Landmarkbio has 1 investor. Key investors include Artis BioSolutions.
Landmarkbio operates through Landmark Bio® Llc.
Yes. Landmarkbio was acquired by Artis BioSolutions in April 2025.